141 results on '"Griffin, Tomás P"'
Search Results
2. Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)
3. Chronic Kidney Disease Is Characterized by Expansion of a Distinct Proinflammatory Intermediate Monocyte Subtype and by Increased Monocyte Adhesion to Endothelial Cells
4. Reference intervals for commonly requested biochemical and haematological parameters in a healthy Irish adult Caucasian population
5. Thyroid Dysfunction and Chronic Kidney Disease: Unravelling the Connection
6. Vitamin D and SARS-CoV-2 infection—evolution of evidence supporting clinical practice and policy development: A position statement from the Covit-D Consortium
7. On the association between circulating biomarkers and atherosclerotic calcification in a cohort of arterial disease participants
8. Social deprivation and diabetic kidney disease: A European view.
9. Impact of the COVID-19 lockdown on the vitamin D status of people in the West of Ireland.
10. COVID-19 in adults: test menu for hospital blood science laboratories
11. UK's Association of British Clinical Diabetologist's Diabetes Technology Network (ABCD-DTN): Best practice guide for hybrid closed-loop therapy
12. Impact of pulsed electric field pre-treatment on nutritional and polyphenolic contents and bioactivities of light and dark brewer's spent grains
13. The importance of standardisation of measurement and reference intervals for detection of phaeochromocytoma and paraganglioma (PPGL)
14. Comparing Glucose Outcomes Following Face-to-Face and Remote Initiation of Flash Glucose Monitoring in People Living With Diabetes
15. UK's Association of British Clinical Diabetologist's Diabetes Technology Network (ABCD‐DTN): Best practice guide for hybrid closed‐loop therapy
16. Influence of Referral to a Combined Diabetology and Nephrology Clinic on Renal Functional Trends and Metabolic Parameters in Adults With Diabetic Kidney Disease
17. Plasma dephosphorylated-uncarboxylated Matrix Gla-Protein (dp-ucMGP): reference intervals in Caucasian adults and diabetic kidney disease biomarker potential
18. Human mesenchymal stromal cells broadly modulate high glucose-induced inflammatory responses of renal proximal tubular cell monolayers
19. Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study.
20. sj-docx-1-dst-10.1177_19322968231176531 – Supplemental material for Comparing Glucose Outcomes Following Face-to-Face and Remote Initiation of Flash Glucose Monitoring in People Living With Diabetes
21. Reference intervals for clinical biochemistry and haematology tests during normal pregnancy
22. The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease
23. Remote capillary blood collection forHbA 1cmeasurement during the COVID ‐19 pandemic: A laboratory and patient perspective
24. How Should Secondary Causes of Diabetes Be Excluded?
25. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone–renin ratio in chronically treated hypertension
26. Multiplex Serum Biomarker Assays Improve Prediction of Renal and Mortality Outcomes in Chronic Kidney Disease
27. Remote capillary blood collection for HbA1c measurement during the COVID‐19 pandemic: A laboratory and patient perspective.
28. High frequency of potential entrapment gaps in beds in an acute hospital
29. Burden of chronic kidney disease and rapid decline in renal function among adults attending a hospital-based diabetes center in Northern Europe
30. In men who are overweight or obese, adding testosterone therapy reduced glucose intolerance/T2DM
31. Vitamin D and SARS-CoV-2 infection—evolution of evidence supporting clinical practice and policy development
32. Protocol for the Diabetes Technology Network UK and Association of British Clinical Diabetologists’ closed-loop insulin delivery audit programme.
33. In T2DM, weekly insulin icodec did not differ from daily glargine for reducing HbA1c or significant/severe hypoglycemia
34. Reference intervals for commonly requested biochemical and haematological parameters in a healthy Irish adult Caucasian population
35. SGLT2 inhibitors increase risk for diabetic ketoacidosis in type 2 diabetes
36. Biallelic CYP24A1 variants presenting during pregnancy: clinical and biochemical phenotypes
37. Higher risk of vitamin D insufficiency/deficiency for rural than urban dwellers
38. COVID-19: the older adult and the importance of vitamin D sufficiency
39. Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy
40. Normocalcemia in the Face of Marked Hypervitaminosis D: The Utility of Vitamin D Metabolite Profiling
41. The aldosterone to renin ratio in the diagnosis of primary aldosteronism: Promises and challenges
42. Chronic Kidney Disease Severity Is Associated With Selective Expansion of a Distinctive Intermediate Monocyte Subpopulation
43. COVID-19 in adults: test menu for hospital blood science laboratories.
44. A core outcome set for studies of gestational diabetes mellitus prevention and treatment.
45. Defining reference intervals for a serum growth differentiation factor-15 (GDF-15) assay in a Caucasian population and its potential utility in diabetic kidney disease (DKD)
46. 183Observation of Bone Turnover Marker Trends and Association with Bone Protection Medications and Clinical Frailty Scale among Frail Older Adults
47. 124Understanding Vitamin D Levels in a Population of Frail Older Adults
48. 213The Effect of Pre-Admission Vitamin D Supplementation on the Clinical Status of Frail Older Adults
49. Biallelic CYP24A1variants presenting during pregnancy: clinical and biochemical phenotypes
50. Defining reference intervals for a serum growth differentiation factor-15 (GDF-15) assay in a Caucasian population and its potential utility in diabetic kidney disease (DKD).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.